doi: 10.1111/cbdd.14180
What foods are suitable
Standard AOD-9604 Dosing : Dose: 0.20.3 mg per injection Frequency: Once or twice daily Timing: Morning: Ideally before fasted cardio or 12 hours before breakfast Evening: 13 hours after dinner, before bedtime Targeting Fat Loss Inject into areas with stubborn fat (e.g., abdomen, thighs) Best results occur when combined with exercise and a clean diet Cycle Duration : Loading Phase: 46 weeks of daily use Maintenance Phase: 23 injections per week to sustain results Breaks: Optional 12 week breaks every few months to avoid receptor desensitization Why Timing Matters : Administering AOD-9604 on an empty stomach enhances absorption Pairing with fasted cardio may amplify lipolytic effects Side Effects to Watch For : Mild nausea Headaches Localized irritation at injection site These are rare and typically resolve quickly
Weight reduction mitigates the risk factors for diabetic nephropathy, while blood pressure control is essential in slowing the progression of CKD
The use of a BPC peptide salt according to any of the claims 1 to 9 for the preparation of a compatible, storage-stable pharmaceutical composition according to claim 10 for the treatment of:disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes pancreatitis, hypotension and Parkinson's disease;dysfunctions or hyperfunctions of somatosensory nerves, in particular, sensory neuropathy, postherpetic neuralgia, atopic dermatitis, impaired healing of injured tissue, acquired cold and heat urticaria, psoriasis, bullous pemphigoid, eczema, photodermatoses, chronic arthritis, gastrointestinal lesions and specific or non-specific hyperreactivity of upper and lower respiratory tracts (asthma, rhinitis);endothelium disturbances;wounds, ulcers;conditions relating to acute and/or chronic inflammation, in particular, chronic arthritis, and disorders related with delayed type of hypersensitivity, and gastrointestinal lesions;liver disorders, organ lesions induced by free radicals specifically caused by irradiation;disorders connected with cathecholaminergic system disturbances, in particular, schizophrenia, amphetamine challenge effects, drug abuse;stress related conditions;acute pancreatitis
The specific neurons targeted differ
